Tumor-treating fields (TTFields), a noninvasive and innovative therapeutic approach, has emerged as the fourth most effective treatment option for the management of glioblastomas (GBMs), the most deadly primary brain cancer. According to on recent milestone randomized trials and subsequent observational data, TTFields therapy leads to substantially prolonged patient survival and acceptable adverse events. Clinical trials are ongoing to further evaluate the safety and efficacy of TTFields in treating GBMs and its biological and radiological correlations. TTFields is administered by delivering low-intensity, intermediate-frequency, alternating electric fields to human GBM function through different mechanisms of action, including by disturbing cell mitosis, delaying DNA repair, enhancing autophagy, inhibiting cell metabolism and angiogenesis, and limiting cancer cell migration. The abilities of TTFields to strengthen intratumoral antitumor immunity, increase the permeability of the cell membrane and the blood–brain barrier, and disrupt DNA-damage-repair processes make it a promising therapy when combined with conventional treatment modalities. However, the overall acceptance of TTFields in real-world clinical practice is still low. Given that increasing studies on this promising topic have been published recently, we conducted this updated review on the past, present, and future of TTFields in GBMs.
26 February 2021 in IEEE Transactions on Neural Systems and Rehabilitation Engineering
Parkinson’s Disease (PD) is a common neurodegenerative disease which impacts millions of people around the world. In clinical treatments, freezing of gait (FoG) is used as the typical symptom to assess PD patients’ condition. Currently, the assessment of FoG is usually performed through live observation or video analysis by doctors. Considering the aging societies, such a manual inspection based approach may cause serious burdens on the healthcare systems. In this study, we propose a pure video-based method to automatically detect the shuffling step, which is the most indistinguishable type of FoG. Firstly, the RGB silhouettes which only contain legs and feet are fed into the feature extraction module to obtain multi-level features. 3D convolutions are used to aggregate both temporal and spatial information. Then the multi-level features are aggregated by the feature fusion. Skip connections are implemented to reserve information of high resolution and period-wise horizontal pyramid pooling is utilized to fuse both global context and local features. To validate the efficacy of our method, a dataset containing 268 normal gait samples and 362 shuffling step samples is built, on which our method achieves an average detection accuracy of 90.8%. Besides shuffling step detection, we demonstrate that our method can also assess the severity of walking abnormity. Our proposal facilitates a more frequent assessment of FoG with less manpower and lower cost, leading to more accurate monitoring of the patients’ condition.
27 April 2022 in Biomechanics and Modeling in Mechanobiology
The ability to track and follow a specific person is a key prerequisite of service mobile robots in indoor environments. A novel following method is introduced, which uses the sizes changes of torso in image as the following control parameters and the fuzzy PID controller is employed to design the following controller. The sizes of torso in images are obtained with mobile robot vision tracking method which integrates the color features of upper body clothes region matching method with the Unscented Particle Filter (UPF) tracking method. In order to reliably follow a specific person, the parameters of the PID controller are adjusted using PSO (Particle Swarm Optimization). Various experiments are carried out and the results demonstrate the robustness and reliability in person-following.
Background: Treatment-related perfusion studies in Parkinson’s disease (PD) have focused on regional cerebral blood flow (CBF), leaving hemispheric perfusion organization less well characterized.Objectives: To test two competing hypotheses: that treatment alters the magnitude of regional perfusion, or that it reorganizes how perfusion is distributed between hemispheres.Methods: Thirty-nine patients undergoing bilateral subthalamic nucleus deep brain stimulation (STN-DBS) underwent 3T arterial spin labeling in presurgical off-medication, on-medication, and six-month postsurgical on-DBS/off-medication states. Whole-cohort analyses tested treatment-state differences in absolute CBF and in lateralization direction, magnitude irrespective of direction, and direction-independent treatment-related change. Clustering of baseline cortical relative CBF defined Homogeneous (n = 26) and Heterogeneous (n = 13) groups for stratified and group-by-state interaction analyses.Results: MDS-UPDRS III scores improved under both treatments, but no regional CBF difference survived false discovery rate (FDR) correction. By contrast, hemispheric organization differed: lateralization magnitude was greater under DBS than at baseline or under medication, and treatment-related lateralization change was greater under DBS than under medication in posterior cortical, hypothalamic, and thalamic regions, with no consistent shift toward the more or less affected side. Phenotype dependence was anatomically selective: this contrast was greater in the ventral lateral dorsal thalamus in Homogeneous patients and in the insula in Heterogeneous patients. Both phenotype-by-state interactions survived FDR correction; none did for CBF or lateralization magnitude.Conclusions: In PD, treatment-related perfusion changes reflected hemispheric redistribution rather than CBF magnitude. Presurgical perfusion phenotype is a candidate stratification framework, warranting prospective evaluation.